Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-16 Option Award |
2024-05-20 7:13 pm |
N/A N/A |
QUEST DIAGNOSTICS INC | DGX | Diaz Luis Director |
1,482 | $0 | 2,851 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 6:25 pm |
N/A N/A |
QUEST DIAGNOSTICS INC | DGX | Diaz Luis Director |
1,369 | $0 | 1,369 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:00 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Diaz Luis Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:44 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Diaz Luis Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2020-06-26 Option Award(A) |
2020-07-02 7:28 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Diaz Luis Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-29 7:28 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Diaz Luis Director |
13,550 | $0 | 13,550 (Direct) |
View |